Reference : Crossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacol...
Scientific journals : Article
Human health sciences : Dermatology
http://hdl.handle.net/2268/2516
Crossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacological issues.
English
Quatresooz, Pascale mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Pierard, Claudine [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Paquet, Philippe mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Hubert, Pascale mailto [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques >]
Delvenne, Philippe mailto [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques >]
Pierard, Gérald mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
2008
European Journal of Dermatology
John Libbey Eurotext
18
1
6-10
Yes (verified by ORBi)
International
1167-1122
Montrouge
France
[en] Aminoquinolines/therapeutic use ; Antineoplastic Agents/therapeutic use ; Carcinoma, Squamous Cell/diagnosis/drug therapy/pathology ; Humans ; Keratosis/diagnosis/drug therapy/etiology/pathology ; Photochemotherapy ; Precancerous Conditions/diagnosis/drug therapy/etiology/pathology ; Receptor, Epidermal Growth Factor/antagonists & inhibitors ; Skin Neoplasms/diagnosis/drug therapy/pathology ; Sunlight/adverse effects
[en] Actinic keratoses (AKs) and their derived squamous cell carcinomas are distinctive lesions forming a continuum in a multi-step carcinogenesis process. They are typically found on chronically sun exposed skin. AKs merit to be recognized as such and to be distinguished from squamous cell carcinomas both conceptually and for therapeutic implications. The histological differences between these lesions are well defined and should not be blurred. A brief review is presented about the biological features responsible for AKs and the clinicopathologically distinctive aspects of these lesions. In addition, recent findings are presented about pharmacotherapy using anti-epidermal growth factor receptors, imidazoquinolines, diclofenac-hyaluronan, and methyl aminolevulinate photodynamic therapy.
http://hdl.handle.net/2268/2516
10.1684/ejd.2008.0303

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
CROSSROADS.pdfNo commentaryAuthor postprint176.73 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.